Home
Contact Us
Pay My Dues
Donate
Healthcare Classified Ads
About Us
Executive Committee
Other AAMS Committees
Mission Statement
AAMS History ►
30 Years in Photos
11th Armenian Medical World Congress
“Uniting for a Healthy Future”
Heroes and Healers
Directory
Join AAMS
Projects
United States
Armenia
Gallery
Events
Events
Past Events
“Your Health” TV Program Archive
Scholarship Program
Our Scholarship Program
United States Scholarship Recipients
Armenia Scholarship Recipients
Webinars
AAMS’ 18th Annual HYBRID CME & CDE Las Vegas Getaway
Name
*
First
Last
Title
*
Specialty
*
Email
*
Phone
*
Member of AAMS
*
Yes
No
Specialty Type
*
Physician
Dentist
Non-Physician
License Number
*
Lymphoma: A Brief Overview of Developments
Special Code 1
*
Therapy
Cancer
Chemotherapy
Lymphoma
Special Code 2
*
Neoplasm
T-cell lympohma
Radiotherapy
Anaplastic
Which of the following lymphomas is considered a very high-grade lymphoma?
*
Burkitt lymphoma
Mantle cell lymphoma
Diffuse large B-cell lymphoma
Follicular lymphoma
As of 2022, the implementation of CAR-T therapy is used in which line of therapy for diffuse large B-cell lymphoma?
*
First-line
Second line
Third line
Fourth line
Which of the following lymphomas this considered an indolent lymphoma?
*
Burkitt lymphoma
Mantle cell lymphoma
Diffuse large B-cell lymphoma
Follicular lymphoma
List any barriers that you must overcome to implement your planned improvements or changes
Share any comments you would like about content or presenter(s)
List topics you would like covered at future AAMS CME/CDE webinars:
What specifically will you change in your practice based on the content of this webinar?